Regen BioPharma Balance Sheet (2013-2026)

Reported Financials

Regen BioPharma Quarterly Balance Sheet

Periods 52 quarters

Latest Jun 2026

Regen BioPharma balance sheet data for the quarter ended Jun 2026. This balance sheet covers 52 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.19M	0.73M	0.35M	0.23M	0.11M	0.05M	0.04M	0.09M	692.00	0.12M	0.12M	0.08M	0.06M	716.00	135.00	0.00M	0.00M	0.07M	0.00M
Short-term InvestmentsInvestments (Current)										0.45M				0.04M	0.04M	0.04M
Cash & Current Investments	0.19M	0.73M	0.35M	0.23M	0.11M	0.05M	0.04M	0.09M	692.00	0.57M	0.12M	0.08M	0.06M	0.04M	0.04M	0.04M	0.00M	0.07M	0.00M
Receivables - NetNet Receivables	0.19M	0.21M	0.24M	0.27M	0.30M	0.25M	0.13M	0.08M	0.06M		0.04M	0.04M	0.07M	0.09M	0.12M	0.15M	0.18M	0.20M	0.23M	0.29M
Receivables - OtherOther Receivables
Receivables	0.19M	0.21M	0.24M	0.27M	0.30M	0.25M	0.13M	0.08M	0.06M		0.04M	0.04M	0.07M	0.09M	0.12M	0.15M	0.18M	0.20M	0.23M	0.29M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets		0.05M	0.04M	0.03M	0.03M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.05M	0.05M	265.00	200.00	200.00	200.00
Current Assets	0.38M	0.99M	0.64M	0.54M	0.44M	0.34M	0.19M	0.18M	0.06M	0.13M	0.14M	0.12M	0.15M	0.14M	0.17M	0.15M	0.18M	0.27M	0.24M
Non-Current Assets
Long-Term Investments														0.02M			0.02M
Other Non-Current Assets	1.05M	0.22M	0.09M	0.09M	0.25M	0.22M	0.22M	0.22M	0.22M	0.22M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M
Non-Current Assets	1.05M	0.22M	0.09M	0.09M	0.25M	0.22M	0.22M	0.22M	0.22M	0.22M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M
Assets	1.43M	1.21M	0.74M	0.63M	0.69M	0.56M	0.41M	0.41M	0.29M	0.35M	0.16M	0.14M	0.17M	0.16M	0.19M	0.17M	0.20M	0.27M	0.24M
Liabilities
Current Liabilities
Accounts Payables	1.27M	1.27M	1.27M	1.27M	1.27M	0.03M	1.27M	1.26M	1.26M	0.03M	0.04M	1.26M	0.03M	0.03M	0.04M	0.03M	0.03M	0.00M	0.01M
Notes Payables	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.10M	0.05M	0.00M		0.50M	0.11M	0.21M	0.78M	1.01M	0.97M	0.73M
Payables	1.27M	1.27M	1.27M	1.27M	1.27M	0.03M	1.27M	1.26M	1.26M	0.13M	0.09M	1.26M	0.03M	0.53M	0.14M	0.24M	0.81M	1.01M	0.98M	0.73M
Accumulated Expenses	0.96M	0.95M	0.66M	0.66M	0.69M	0.69M	0.30M	0.31M	0.33M	1.64M	0.36M	0.34M	0.36M	1.66M	1.71M	1.75M	1.77M	1.84M	1.85M
Other Accumulated Expenses										0.04M			0.04M	0.02M	0.04M	0.02M	0.02M	0.10M	0.10M
Short term Debt
Current Deferred Revenue	1.88M									1.61M				1.47M	1.43M	1.40M	1.37M	1.34M	1.31M
Total Current Liabilities	13.85M	14.70M	10.49M	77.38M	9.04M	8.60M	5.30M	5.34M	5.31M	5.31M	5.25M	5.17M	5.33M	5.38M	5.87M	5.87M	6.01M	6.56M	6.81M
Non-Current Liabilities
Non-Current Debt										0.15M	0.15M	0.14M
Convertible Debt	2.34M	2.13M	1.26M	2.99M	1.57M	1.26M	0.50M	0.50M	0.50M	0.50M	0.50M	0.50M	0.50M
Minority Interest
Other Non-Current Liabilities	7.17M	6.89M	3.93M	70.56M	3.65M	3.55M	1.44M	1.40M	1.40M	1.40M	1.40M	1.40M	1.40M	1.40M	1.82M	1.69M	1.78M	2.08M	2.46M
Total Non-Current Liabilities	6.67M	7.81M	6.56M	6.82M	5.39M			3.94M	3.91M	0.15M	0.15M	0.14M		3.97M	4.05M	4.18M	4.23M	4.48M	4.35M
Total Liabilities	13.85M	14.70M	10.49M	77.38M	9.04M	8.60M	5.30M	5.34M	5.31M	5.46M	5.40M	5.32M	5.33M	5.38M	5.87M	5.87M	6.01M	6.56M	6.81M
Shareholder's Equity
Total Debt	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.25M	0.20M	0.14M		0.50M	0.11M	0.21M	0.78M	1.01M	0.97M	0.73M
Common Equity	-12.41M	-13.49M	-9.76M	-76.75M	-8.35M	-8.04M	-4.88M	-4.93M	-5.03M	-5.10M	-5.24M	-5.18M	-5.16M	-5.22M	-5.68M	-5.70M	-5.82M	-6.28M	-6.57M
Liabilities and Shareholders Equity	1.43M	1.21M	0.74M	0.63M	0.69M	0.56M	0.41M	0.41M	0.29M	0.35M	0.16M	0.14M	0.17M	0.16M	0.19M	0.17M	0.20M	0.27M	0.24M
Retained Earnings	-21.96M	-23.35M	-20.70M	-87.79M	-20.83M	-20.91M	-19.27M	-19.32M	-19.42M	-19.75M	-20.10M	-20.22M	-20.35M	-20.42M	-20.93M	-20.95M	-21.12M	-21.69M	-22.66M
Preferred Shares	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.07M	45.00		40.00	45.00	40.00	47.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M

Regen BioPharma Balance Sheet API

Pull Regen BioPharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "RGBP", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=RGBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Regen BioPharma RGBP Balance Sheet (2013-2026)

Regen BioPharma Quarterly Balance Sheet

Regen BioPharma Balance Sheet API

Create an account

Sign In

Reset Password